Skip to content
Politically.com Search all
Menu

Louisiana 2026

HB 1223

ECONOMIC DEVELOPMENT: Establishes the Louisiana Clinical Trial Competitiveness and Patient Access Act

Open original source Back to bills
Source: Open States / PluralLatest available (refresh failed). Last refreshed: 2026-09-09 19:11:02 UTC.

Official record

Measure details

Jurisdiction
Louisiana
Session
2026
Chamber
lower
Classification
bill
Subjects
Not supplied
Introduced / first action
2026-03-31 00:00:00

Sponsors

Source-supplied history

Actions

  1. Signed by the Governor. Becomes Act No. 886.

    became-law, executive-signature

  2. Effective date: 06/09/2026.

  3. Sent to the Governor for executive approval.

    executive-receipt

  4. Signed by the President of the Senate.

  5. Enrolled and signed by the Speaker of the House.

    enrolled

  6. Read by title, roll called, yeas 98, nays 0, Senate amendments concurred in.

  7. Scheduled for concurrence on 05/29/2026.

  8. Rules suspended. The amended bill was read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

    passage

  9. Received from the Senate with amendments.

    receipt

  10. Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.

    reading-3

  11. Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.

  12. Reported with amendments.

    committee-passage-favorable

  13. Read second time by title and referred to the Committee on Commerce, Consumer Protection and International Affairs.

    reading-2, referral-committee

  14. Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

    reading-1

  15. Called from the calendar.

  16. Read third time by title, amended, roll called on final passage, yeas 94, nays 0. Finally passed, title adopted, ordered to the Senate.

    passage

  17. Called from the calendar.

  18. Read by title, returned to the calendar.

  19. Notice given.

  20. Scheduled for floor debate on 05/11/2026.

  21. Called from the calendar.

  22. Read by title, returned to the calendar.

  23. Notice given.

  24. Scheduled for floor debate on 05/07/2026.

  25. Read by title, returned to the calendar.

  26. Notice given.

  27. Scheduled for floor debate on 05/05/2026.

  28. Scheduled for floor debate on 04/27/2026.

  29. Read by title, amended, ordered engrossed, passed to 3rd reading.

    reading-3

  30. Reported with amendments (12-0).

    committee-passage-favorable

  31. Read by title, under the rules, referred to the Committee on Commerce.

    referral-committee

  32. Read by title. Lies over under the rules.

Documents and versions

Official links

When supplied by the API

Related measures

No resolvable related measure is supplied.